Benitec Biopharma (BNTC) Q4 2023 Earnings

13FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.76
-1.89
-1.03
-0.16

Details

Expected EPS
N/A
Actual EPS
-2.64
Surprise EPS
-2.64
Surprise Percent
+∞%

Description

Benitec Biopharma (BNTC) has reported earnings of -2.64 per share for Q4 2023.

0 Comments

Share your thoughts